Contraception
From the Journals
Self-administered subcutaneous Depo-Provera ‘feasible and acceptable’
Self-injected contraception “has potential to reduce barriers and disparities in access,” wrote Dr. Julia E. Kohn.
From the Journals
Newer hormonal contraception formulations linked to breast cancer risk*
The elevated risk should be weighed against the benefits of contraception, researchers said.
Conference Coverage
Women with adult acne need more treatment options and support
The emotional impact of acne in adult women can be similar to that of psoriasis, according to Dr. Baldwin.
Conference Coverage
Don’t let GDM history limit contraception choices
WASHINGTON – The risks associated with unplanned pregnancy are generally higher than those from contraception.
Conference Coverage
LARCs remain best contraception for teens
CHICAGO – Only 4% of teens using contraception choose LARCs, the most effective contraceptive choice.
From the Journals
Many women have unprotected sex in year after bariatric surgery
Results point to a need for presurgical contraceptive counseling.
Commentary
Contraception coverage rollback is discriminatory
Policy shows the Trump administration’s lack of concern for women’s health.
Feature
Trump administration narrows contraceptive mandate
HHS issued a rule that dramatically expands religious exemptions to the Affordable Care Act’s contraception coverage mandate.
Conference Coverage
Copper IUDs increase bacterial vaginosis risk
PARK CITY, UTAH – These IUDs cause heavier and longer menstrual bleeding, which in turn disrupts the vaginal microbiome.
From the Journals
Oral contraceptive use linked to lower rheumatoid arthritis risk
The decrease in risk was seen only in women with ACPA-positive RA.
News
FDA extends Liletta IUD duration of use to 4 years
The agency extended the duration of use for the hormonal IUD by 1 year.